Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence-Reference-Cited by-同舟云学术

Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence

Published:2002-09 Issue:1-2 Volume:130 Page:224-232
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Wang Xiong-Biao,Kakoulidou Maria,Giscombe Ricardo,Qiu Qianhui,Huang DeRen,Pirskanen Ritva,Lefvert Ann Kari

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference45 articles.

1. CD28 function: a balance of co-stimulatory and regulatory signals;Bour-Jordan;J. Clin. Immunol.,2002

2. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis;Braun;Tissue Antigens,1998

3. CTLA-4 (CD152) can inhibit T-cell activation by two different mechanisms depending on its level of cell-surface expression [In Process Citation];Carreno;J. Immunol.,2000

4. AU-rich elements: characterization and importance in mRNA degradation;Chen;Trends Biochem. Sci.,1995

5. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression;Chuang;J. Immunol.,1997

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble form of immune checkpoints in autoimmune diseases;Journal of Autoimmunity;2024-07

2. CTLA-4 expression and polymorphisms in Schizophrenia; a systematic review of literature;Molecular Biology Reports;2024-03-23

3. A nanobody based ultrasensitive electrochemical biosensor for the detection of soluble CTLA-4 –A candidate biomarker for cancer development and progression;Biosensors and Bioelectronics;2023-12

4. Current understanding of CTLA-4: from mechanism to autoimmune diseases;Frontiers in Immunology;2023-07-11